Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2007
12/06/2007US20070281333 Metal-binding motif compositions and methods
12/06/2007US20070281332 Protease Variants
12/06/2007US20070281327 Methods of Screening for Modified Antibodies With Agonistic Activities
12/06/2007US20070281320 Novel Bioactive Lipid Derivatives, and Methods of Making and Using Same
12/06/2007US20070281306 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
12/06/2007US20070280985 Methods of Establishing Intercellular Communication in an Endothelial Cell Layer and Uses Thereof
12/06/2007US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases
12/06/2007US20070280951 Cell Death Inducing Agents
12/06/2007US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof
12/06/2007US20070280945 Human antibody or antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KD of about <500 pM and blocks IL-6 activity with an IC50 of <200 pM;low dissociation kinetics; pharmakinetics; anticarcinogenic agents; melanoma; antitumor agents; antiarthritis agents; antiinflammatory agents
12/06/2007US20070280931 Antibody variants
12/06/2007US20070280884 Insect poison allergens with reduced IgE reactivity and method for producing the same
12/06/2007US20070280881 Dimeric antibody having two antibodies that are non-covalently associated to form a tetravalent antibody dimer having four antigen-biding sites; neoplastic disorders such as colon cancer; autoimmune disorders
12/06/2007CA2653661A1 Humanized anti-human osteopontin antibody
12/06/2007CA2653101A1 Compositions and methods for the delivery of nitric oxide
12/06/2007CA2652894A1 Genetically encoded fluorescent coumarin amino acids
12/05/2007EP1862550A1 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
12/05/2007EP1862548A1 Death domain containing receptor 4 (DR4 : death receptor 4), member of the TNF-receptor superfamily and binding to trail (APO2-L)
12/05/2007EP1862475A1 Polymer conjugates of neublastin and methods of using same
12/05/2007EP1862474A1 Reagent for the diagnosis of rheumatoid arthritis
12/05/2007EP1862178A1 Use of HLTF antibodies for diagnosis and treatment of cancer
12/05/2007EP1861508A2 Cd38 modulated chemotaxis
12/05/2007EP1861507A2 Optimization of heterologous polypeptide expression
12/05/2007EP1861506A2 Cellulases, nucleic acids encoding them and methods for making and using them
12/05/2007EP1861505A1 Process for microbial production of a valuable compound
12/05/2007EP1861504A2 Glycoengineering in mushrooms
12/05/2007EP1861499A1 Methods and compositions for producing active vitamin k-dependent proteins
12/05/2007EP1861498A2 Expression vectors for enhanced transient gene expression and mammalian cells expressing them
12/05/2007EP1861420A1 Fermentation process for the production of diphtheria toxin
12/05/2007EP1434483B1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
12/05/2007EP1305399B1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
12/05/2007EP1303621B1 Novel cacao endoproteinases and their use in the production of cocoa flavour
12/05/2007EP1222207B1 C-peptide for the improved production of insulin and insulin analogues
12/05/2007EP0941252B1 Anti-p53 single-chain antibody fragments and their uses
12/05/2007EP0708831B2 Cell-density enhanced protein tyrosine phosphatases
12/05/2007CN101084302A Recombinant microorganism
12/05/2007CN101084233A Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins
12/05/2007CN101084004A Blood pressure lowering peptides in a single enzymatic step
12/05/2007CN101082046A Heterogenetic expression method for recombined pea albumin subfraction PA1b gene
12/05/2007CN101081869A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081868A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081867A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081232A Yak bone marrow glair polypeptides bone extract and the composition thereof and the preparing method
12/05/2007CN100352935C Method for producing dipeptide
12/05/2007CN100352925C RNP originating in paramyxovirus
12/05/2007CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
12/05/2007CN100352844C Recombinant anti-osteopontin antibody and use thereof
12/05/2007CN100352836C Novel depsipeptides and process for preparing same
12/05/2007CN100352835C Corn albumen powder polypeptide, its separation method and uses
12/05/2007CN100352834C Polypeptide capable of suppressing weed seed germination and rootage, and separation method and uses
12/05/2007CN100352833C Polypeptide for suppressing weed seed germination and rootage, and separation method and uses
12/05/2007CN100352501C Cripto blocking antibodies and uses thereof
12/05/2007CN100352499C High mannose proteins and method of making mannose proteins
12/04/2007US7304145 Wound healing agents; anticancer agents; cardiovascular disorders
12/04/2007US7304144 Antibodies binding to human TSLP Polypeptides
12/04/2007US7304143 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
12/04/2007US7304141 Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
12/04/2007US7304140 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
12/04/2007US7304135 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
12/04/2007US7304134 PRO9742 polypeptides
12/04/2007US7304126 Induction of chondrocyte proliferation/ differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
12/04/2007US7304031 Methods and means for producing proteins with predetermined post-translational modifications
12/04/2007US7303914 Monoclonal antibody against human hepatoma and use thereof
12/04/2007US7303903 Production of weakly active or inactive mutants of alkaline phosphatase and their expression in yeast
12/04/2007US7303899 Expression of granular starch hydrolyzing enzymes in Trichoderma and process for producing glucose from granular starch substrates
12/04/2007US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R
12/04/2007US7303895 Choline transport like (CTL) membrane proteins involved in choline transport
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007US7303877 Using trangenic fungus to produce heterologous proteins; bioreactors
12/04/2007US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies
12/04/2007CA2395453C Plant lesion formation suppressing gene, spl7 and use thereof
12/04/2007CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
12/04/2007CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007CA2224724C Subunit vaccine against flavivirus infection
11/2007
11/29/2007WO2007136800A2 Dc offset mitigation in a single-supply amplifier
11/29/2007WO2007135958A1 System for cell surface layer expression of gram-negative bacterium
11/29/2007WO2007134539A1 Antibody to autoantigen and/or species high conservation antigen and its preparing method
11/29/2007WO2007089578A3 Method for selecting phosphate binder and its uses thereof
11/29/2007WO2007084583A3 Soluble fragments of the sars-cov spike glycoprotein
11/29/2007WO2007044591A3 Vasoactive intestinal polypeptide pharmaceuticals
11/29/2007WO2005003294A3 Unnatural reactive amino acid genetic code additions
11/29/2007US20070276133 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
11/29/2007US20070276128 Stabilized Proteins with Engineered Disulfide Bonds
11/29/2007US20070276126 Cell adhesion and extracellular matrix proteins
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007US20070275889 Gene Expression Technique
11/29/2007US20070275888 Preventive/Remedy for Cancer
11/29/2007US20070275882 Nature-Identical Erythropoietin
11/29/2007US20070275871 Epo Mimetic Peptides and Fusion Proteins
11/29/2007US20070275444 Contacting chiral primary amine, omega-transaminase, and amino acceptor to convert into ketone; stereospecific; gene expression; can be used to enrich enantiomerically a mixture of chiral amines or to synthesize stereoselectively one of a pair of chiral amines
11/29/2007US20070275442 Side Chain Deuterated Amino Acids Methods Of Use
11/29/2007US20070275441 Ocular Tissue Modification
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275437 Antibodies to G protein-coupled receptor
11/29/2007US20070275421 Determining cell proliferation by contacting the test sample of human fluids with an antibody directed against Minichromosome Maintenance protein 7 (MCM7 protein); and determining the amount of binding of said antibody to said test sample
11/29/2007US20070275419 Tumor tag and the use thereof
11/29/2007US20070275393 Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
11/29/2007US20070275391 Novel g-protein coupled receptors and dna sequences thereof
11/29/2007US20070275385 Rapid Screening Method of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom
11/29/2007US20070275384 Assessing human predisposition to a febrile seizure disorder